Blink's technology is based on research carried out by the founding scientists Facundo Batista, at Cancer Research UK's London Research Institute in collaboration with Vincenzo Cerundolo at the University of Oxford.
Cancer Research Technology, the quasi-corporate venturing unit of charity Cancer Research UK, and venture capital firm Kurma Life Sciences Partners have spun out Blink Therapeutics.
Blink’s technology is based on research carried out by the founding scientists Facundo Batista, at Cancer Research UK’s London Research Institute in collaboration with Vincenzo Cerundolo at the University of Oxford.
Kurma has committed up to £1.1m ($1.8m) as seed financing and up to £6.6m in further financing for Blink.
Richard Treisman, director of Cancer…
